Morpholine → HCID 178433776, compound
Reaction equation
Cl[C:2]1[CH:7]=[C:6](Cl)[N:5]2[N:9]=[C:10]([CH3:23])[C:11]([CH2:12][C:13]3[C:22]4[C:17](=[CH:18][CH:19]=[CH:20][CH:21]=4)[CH:16]=[CH:15][CH:14]=3)=[C:4]2[N:3]=1.[OH-:24].[Na+].[NH:26]1[CH2:31][CH2:30][O:29][CH2:28][CH2:27]1>O1CCCC1.C(O)C>[CH3:23][C:10]1[C:11]([CH2:12][C:13]2[C:22]3[C:17](=[CH:18][CH:19]=[CH:20][CH:21]=3)[CH:16]=[CH:15][CH:14]=2)=[C:4]2[N:3]=[C:2]([N:26]3[CH2:31][CH2:30][O:29][CH2:28][CH2:27]3)[CH:7]=[C:6]([OH:24])[N:5]2[N:9]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 50 °C
Procedure
To a solution of 5,7-dichloro-2-methyl-3-(1-naphthalenylmethyl)pyrazolo[1,5-a]pyrimidine (0.06 g, 0.175 mmol), prepared using a similar route as was used in Example 1 step c, in Tetrahydrofuran (THF) (5 mL), was added sodium hydroxide (0.877 mL, 1.753 mmol). The reaction was stirred at rt for 18 and 50° C. for 7 h. The reaction mixture was acidified and extracted with EtOAc (80 mL×2). The organic phases were combined, dried and concentrated. To the crude mixture in ethanol (1 mL) was added morpholine (0.076 mL, 0.877 mmol). The reaction mixture was subjected to MW irradiation at 150° C. for 3 h. The reaction mixture was concentrated. The residue was purified by reverse-phase HPLC (25˜55% CH3CN (0.1% TFA)/Water (0.1% TFA)) to give the product (0.02 g, 9%). 1H NMR (400 MHz, DMSO-d6) δ ppm 2.05 (br. s., 3H) 3.30 (m, 4H) 3.67 (m, 4H) 4.37 (br. s., 2H) 5.03 (br. s., 1H) 7.01 (br. s., 1H) 7.40 (t, J=7.71 Hz, 1H) 7.56 (m, 2H) 7.79 (d, J=8.34 Hz, 1H) 7.95 (d, J=7.33 Hz, 1H) 8.27 (m, 1H); LC/MS: MS (ES+) m/e 375.1 [M+H]+.
Workup
- extractionextracted with EtOAc (80 mL×2)
- customdried
- concentrationconcentrated
- customThe reaction mixture was subjected to MW irradiation at 150° C. for 3 h
- concentrationThe reaction mixture was concentrated
- customThe residue was purified by reverse-phase HPLC (25˜55% CH3CN (0.1% TFA)/Water (0.1% TFA))
Sources & evidence
- ORD record
- ord-ecdd92495cf24addaeb1437f6b41100d
- Source dataset
- uspto-grants-2015_08
- Patent number
- US09096605B2
Reaction notes
Loading…